JOHN NORTHCOTT - SVP & Chief Commercial Officer at NEKTAR THERAPEUTICS

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP & Chief Commercial Officer
Issuer Symbol
NKTR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by JOHN NORTHCOTT since 03 Feb 2025

Holdings reported by JOHN NORTHCOTT for NEKTAR THERAPEUTICS

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 223,210 $109,373 $0.4900 16 May 2022 Direct
Stock Option 67,150 16 Dec 2021 Direct Common Stock

Transactions reported by JOHN NORTHCOTT for NEKTAR THERAPEUTICS

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.